Kynam Capital Management »

Insmed shares owned by Kynam Capital Management

Quarter-by-quarter ownership of Insmed (INSM) shares owned by Kynam Capital Management from 13F filings

Historical chart of Kynam Capital Management investment in Insmed

Tip: Access up to 7 years of quarterly data

All positions including Insmed held by Kynam Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Insmed by Kynam Capital Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $67M 1.0M 67.00

More positions owned by Kynam Capital Management

Natera (NTRA)
Vertex Pharmaceuticals Incorporated Put Option (VRTX)
Celldex Therapeutics Com New (CLDX)
Syndax Pharmaceuticals (SNDX)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Dynavax Technologies Corp Com New (DVAX)
Cogent Biosciences (COGT)
Insmed Com Par $.01 Call Option (INSM)
Vaxcyte (PCVX)
Vera Therapeutics Cl A (VERA)
BioCryst Pharmaceuticals (BCRX)
Protagonist Therapeutics (PTGX)
2seventy Bio Common Stock (TSVT)
Miragen Therapeutics (VRDN)
Wave Life Sciences SHS (WVE)

View all positions for Kynam Capital Management

Top funds holding Insmed

Vanguard Group
BlackRock
BlackRock
T. Rowe Price Associates
Darwin Global Management
Capital Research and Management Company - Division 3
State Street Corporation
Baker Bros. Advisors
Geode Capital Management
Jpmorgan Chase & Co
Artisan Partners Limited Partnership
Macquarie Group
Franklin Resources
Suvretta Capital Management
Alliancebernstein

View all funds holding Insmed